Asset Acquisition (Details Narrative) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Oct. 09, 2024 |
Dec. 31, 2025 |
|
| Asset Acquisition [Line Items] | ||
| Accrued expenses and other current liabilities | $ 873 | |
| Purchase price contingent consideration | $ 4,000 | |
| Sequence LifeScience Inc [Member] | ||
| Asset Acquisition [Line Items] | ||
| Asset Acquisition, Price of Acquisition, Expected | 5,500 | |
| Upfront payment | 1,000 | |
| Monthly milestone payments | 4,000 | |
| Prior payment to related party | $ 500 | |
| Accured milestone payments | 3,127 | |
| Increase (Decrease) in Other Accrued Liabilities | 2,477 | |
| Asset Acquisition, Contingent Consideration, Liability | $ 650 |
| X | ||||||||||
- Definition Accured milestone payments. No definition available.
|
| X | ||||||||||
- Definition Monthly milestone payments. No definition available.
|
| X | ||||||||||
- Definition Prior payment to related party. No definition available.
|
| X | ||||||||||
- Definition Purchase price contingent consideration. No definition available.
|
| X | ||||||||||
- Definition Upfront payment. No definition available.
|
| X | ||||||||||
- Definition Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Amount of liability recognized from contingent consideration in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Purchase price of expected asset acquisition prior to consideration being transferred. Excludes business acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The increase (decrease) during the reporting period in other expenses incurred but not yet paid. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|